Solasta Ventures is a venture capital firm dedicated to investing in innovative companies that aim to advance the standard of care for diseases with unmet medical needs. Leveraging deep scientific expertise and an extensive network, the firm identifies promising therapeutics and discovery platforms with the potential to transform patients' lives worldwide. Established as a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm, Solasta Ventures operates with a team possessing over 30 years of combined experience in healthcare investments and drug development.

( The firm's investment focus includes therapeutics and technology that transform care for patients in U.S. and global markets, strong management teams capable of efficiently utilizing capital, and potential for partnerships with global pharmaceutical companies, including those in their South Korean network.